Earnings History Data for Relmada Therapeutics, Inc. (RLMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Relmada Therapeutics, Inc.

Relmada Therapeutics Inc. is a clinical stage, public specialty pharmaceutical company. The Company is developing LevoCap ER, an abuse resistant, once-a-day sustained release dosage form of the opioid analgesic levorphanol; d-methadone, the NDMA receptor antagonist for neurophatic pain; BuTab ER, an oral dosage form of the opioid analgesic buprenorphine and MepiGel, a FDA Orphan Drug designated topical formulation of the local anesthetic mepivacaine. Relmada Therapeutics Inc. is based in New York.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
19-03-2024 AH RLMD Relmada Therapeutics, Inc. 163.14 -0.84 -0.88 -1.26 Relmada Therapeutics GAAP EPS of -$0.84
[3/19/2024 4:22 PM]
4.44 -0.93 
(-17.32%)
5.37 0.0 
(0.00%)
2.00 - 7.22 662,198 160,000 769
08-11-2023 AH RLMD Relmada Therapeutics, Inc. 94.21 -0.73 -0.95 -1.31 Relmada Therapeutics GAAP EPS of -$0.73
[11/8/2023 4:17 PM]
2.96 -0.04 
(-1.33%)
3.08 0.08 
(2.67%)
1.81 - 6.74 128,874 120,000 795
08-08-2023 AH RLMD Relmada Therapeutics, Inc. 76.45 -0.84 -0.92 -1.33 Relmada Therapeutics GAAP EPS of -$0.84 beats by $0.06
[8/8/2023 4:44 PM]
2.73 0.19 
(7.68%)
2.62 0.08 
(3.15%)
1.81 - 38.68 99,785 70,000 5,701
11-05-2023 AH 4:05 PM ET
(May 11)
RLMD Relmada Therapeutics, Inc. 101.13 -0.87 -1.24 -1.40 Relmada Therapeutics GAAP EPS of -$0.87 beats by $0.02
[5/11/2023 4:17 PM]
2.98 -0.19 
(-5.99%)
3.17 0.0 
(0.00%)
1.81 - 38.68 85,884 180,000 2,807
23-03-2023 AH 4:05 PM ET
(Mar 23)
RLMD Relmada Therapeutics, Inc. 103.09 -1.26 -1.38 -1.80 Relmada Therapeutics Non-GAAP EPS of -$5.30 misses by $1.28
[3/23/2023 4:02 PM]
2.25 -0.07 
(-3.02%)
2.32 0.0 
(0.00%)
1.81 - 38.68 262,288 230,000 551
11-08-2022 AH 4:00 PM ET
(Aug 11)
RLMD Relmada Therapeutics, Inc. 711.08 -1.33 -1.30 -1.56 Relmada Therapeutics GAAP EPS of -$1.33
[8/11/2022 4:20 PM]
29.21 1.39 
(5.00%)
27.74 -0.08 
(-0.29%)
15.73 - 30.95 354,350 200,000 3,364
05-05-2022 AH 4:05 PM ET
(May 5)
RLMD Relmada Therapeutics, Inc. 761.42 -1.40 -1.21 -1.34 Relmada Therapeutics GAAP EPS of -$1.40 misses by $0.13
[5/5/2022 5:15 PM]
21.23 -1.17 
(-5.22%)
22.37 -0.03 
(-0.13%)
16.23 - 39.66 417,050 230,000 343
23-03-2022 AH 4:00 PM ET
(Mar 23)
RLMD Relmada Therapeutics, Inc. 632.43 -1.80 -1.60 -1.28 Relmada Therapeutics GAAP EPS of -$1.80 beats by $0.04
[3/23/2022 4:25 PM]
25.06 1.73 
(7.42%)
23.70 0.37 
(1.59%)
16.23 - 40.00 437,180 279,260 646
11-11-2021 AH 4:05 PM ET
(Nov 11)
RLMD Relmada Therapeutics, Inc. 441.19 -2.44 -1.62 -1.05 Relmada Therapeutics EPS misses by $0.84
[11/11/2021 4:46 PM]
22.80 -2.86 
(-11.15%)
25.66 0.0 
(0.00%)
20.60 - 40.00 128,532 60,000 1,099
10-08-2021 AH 4:10 PM ET
(Aug 10)
RLMD Relmada Therapeutics, Inc. 394.00 -1.56 -1.47 0.00 23.74 0.74 
(3.22%)
21.58 -1.42 
(-6.17%)
20.60 - 40.87 266,205 440,000 2,045
12-05-2021 AH 4:25 PM ET
(May 12)
RLMD Relmada Therapeutics, Inc. 578.95 -1.34 -1.38 -0.72 Relmada Therapeutics EPS beats by $0.06
[5/12/2021 4:27 PM]
33.30 -0.31 
(-0.92%)
33.61 0.0 
(0.00%)
28.40 - 54.00 34,834 50,000 625
23-03-2021 AH After the close
(Mar 23)
RLMD Relmada Therapeutics, Inc. 593.95 -1.28 -1.11 0.00 Relmada Therapeutics EPS misses by $0.25
[3/23/2021 4:31 PM]
31.93 -2.41 
(-7.02%)
35.55 0.0 
(0.00%)
28.40 - 54.00 60,412 60,000 3,208